NARA Discovery
Article Details
← Back to Search Results
Journal Article

Cost-Effectiveness of olaparib plus bevacizumab versus bevacizumab monotherapy as first-line maintenance for patients with advanced ovarian cancer: a analysis from a Chinese healthcare perspective

Pengxiang Cai; Jin Liu; Caifen Yu; Qing Chen; Shan Huang; Lingjun Zeng; Yong Sun; Aiwen Huang
DARU Journal of Pharmaceutical Sciences · Vol. 34, Issue 2 · 2026
View Full Text Download RIS Journal Homepage

Abstract

Abstract is unavailable.

Bibliographic Information

JournalDARU Journal of Pharmaceutical Sciences
PublisherSpringer
Publication Date2026-07-22
Publication Year2026
Volume34
Issue2
Document TypeJournal Article
eISSN2008-2231
DOI10.1007/s40199-026-00621-1

Access Information

NARA Access Coverage2012-01-01~Current
Journal Homepagehttps://www.springer.com/journal/40199
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.